Home > Back to Publisher > Report Information

Qiagen N.V. Market Share Analysis

GlobalData
December 31, 2011
192 Pages - SKU: GBDT6744618

Abstract Table of Contents Search inside this report Related Reports

Qiagen N.V. Market Share Analysis

Summary

GlobalData’s new report, “Qiagen N.V. Market Share Analysis” provides in-depth information on Qiagen N.V.’s market position in the different medical equipment markets it operates in. The report provides Qiagen N.V. market share information in two key market categories - Infectious Immunology and Genetic Testing. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

Global company shares (in Revenues) information for the key markets Qiagen N.V. operates in - In Vitro Diagnostics.
Qiagen N.V.’s company shares (in Revenues) information for all the key countries the company has presence in - Japan, India, Australia, China, Italy, United Kingdom, Spain, France, Germany, United States, Canada and Brazil.
Qiagen N.V.’s company shares (in Revenues) information for all the key market categories the company has presence in - Infectious Immunology and Genetic Testing.
All the key data-points are for 2010 and cover all the key regions - Asia-Pacific, North America, Middle East and Africa, South and Central America and Europe.
Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in..
Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

Develop sales and marketing strategies by identifying who-stands-where in the markets, Qiagen N.V. operates in.
Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to Qiagen N.V.’s market positions.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered: 3.1 In Vitro Diagnostics
4 Company Snapshot: 4.1 Key Information; 4.2 Company Overview; 4.3 Financial Performance; 4.4 SWOT Snapshot; 4.5 Business Overview; 4.6 Major Products and Services
5 History
6 SWOT Analysis: 6.1 Overview; 6.2 Qiagen N.V. Strengths; 6.3 Qiagen N.V. Weaknesses; 6.4 Qiagen N.V. Opportunities; 6.5 Qiagen N.V. Threats
7 Competitors
8 Competitive Landscape: 8.1 In Vitro Diagnostics, Global, Market Share (%), 2010
9 Qiagen N.V. Medical Equipment Market Share Analysis: 9.1 Qiagen N.V., In Vitro Diagnostics, Global, Market Share (2010); 9.2 Qiagen N.V., Asia-Pacific, Market Share (2010); 9.3 Qiagen N.V., Europe, Market Share (2010); 9.4 Qiagen N.V., Middle East and Africa, Market Share (2010); 9.5 Qiagen N.V., North America, Market Share (2010); 9.6 Qiagen N.V., South and Central America, Market Share (2010)
10 Qiagen N.V. Medical Equipment Market Share Analysis by Category: 10.1 Qiagen N.V., In Vitro Diagnostics, Global, Category Revenue Share (2010); 10.2 Qiagen N.V., Asia-Pacific, Category Revenue Share (2010); 10.3 Qiagen N.V., Europe, Category Revenue Share (2010); 10.4 Qiagen N.V., Middle East and Africa, Category Revenue Share (2010); 10.5 Qiagen N.V., North America, Category Revenue Share (2010); 10.6 Qiagen N.V., South and Central America, Category Revenue Share (2010)
11 Key Employees
12 Key Employee Biographies
13 Locations And Subsidiaries: 13.1 Head Office; 13.2 Other Locations & Subsidiaries
14 Financial Deals Landscape: 14.1 Qiagen N.V., Deals Volume Summary, 2006 to YTD 2011
15 Qiagen N.V. Detailed Deal Summary: 15.1 Asset Purchase; 15.2 Partnerships; 15.3 Equity Offering; 15.4 Acquisition
16 Recent Developments: 16.1 Strategy And Business Planning; 16.2 Financial Announcements; 16.3 Research And Development; 16.4 Corporate Communications; 16.5 Legal and Regulatory; 16.6 Product News
17 Appendix: 17.1 Research Methodology; 17.2 Secondary Research; 17.3 Primary Research; 17.4 Models; 17.5 Forecasts; 17.6 Expert Panels; 17.7 GlobalData Consulting; 17.8 Currency Conversion; 17.9 Contact Us; 17.10 Disclaimer
1.1 List of Tables: Table 1: Qiagen N.V., Key Facts, 2010; Table 2: Qiagen N.V., SWOT Analysis, 2010; Table 3: In Vitro Diagnostics, Global, Company Share by Revenue ($m), 2010; Table 4: Qiagen N.V., In Vitro Diagnostics, Global, Revenue ($m) and Market Share (%), 2010; Table 5: Qiagen N.V., In Vitro Diagnostics, Asia-Pacific, Revenue ($m) and Market Share (%), 2010; Table 6: Qiagen N.V., In Vitro Diagnostics, Europe, Revenue ($m) and Market Share (%), 2010; Table 7: Qiagen N.V., In Vitro Diagnostics, Middle East and Africa, Revenue ($m) and Market Share (%), 2010; Table 8: Qiagen N.V., In Vitro Diagnostics, North America, Revenue ($m) and Market Share (%), 2010; Table 9: Qiagen N.V., In Vitro Diagnostics, South and Central America, Revenue ($m) and Market Share (%), 2010; Table 10: Qiagen N.V., In Vitro Diagnostics, Global, Revenue ($m) and Market Share (%) by Category, 2010; Table 11: Qiagen N.V., In Vitro Diagnostics, Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010; Table 12: Qiagen N.V., In Vitro Diagnostics, Australia, Revenue ($m) and Market Share (%) by Category, 2010; Table 13: Qiagen N.V., In Vitro Diagnostics, China, Revenue ($m) and Market Share (%) by Category, 2010; Table 14: Qiagen N.V., In Vitro Diagnostics, India, Revenue ($m) and Market Share (%) by Category, 2010; Table 15: Qiagen N.V., In Vitro Diagnostics, Japan, Revenue ($m) and Market Share (%) by Category, 2010; Table 16: Qiagen N.V., In Vitro Diagnostics, Other Asia-Pacific, Revenue ($m) and Market Share (%) by Category, 2010; Table 17: Qiagen N.V., In Vitro Diagnostics, Europe, Revenue ($m) and Market Share (%) by Category, 2010; Table 18: Qiagen N.V., In Vitro Diagnostics, France, Revenue ($m) and Market Share (%) by Category, 2010; Table 19: Qiagen N.V., In Vitro Diagnostics, Germany, Revenue ($m) and Market Share (%) by Category, 2010; Table 20: Qiagen N.V., In Vitro Diagnostics, Italy, Revenue ($m) and Market Share (%) by Category, 2010; Table 21: Qiagen N.V., In Vitro Diagnostics, Spain, Revenue ($m) and Market Share (%) by Category, 2010; Table 22: Qiagen N.V., In Vitro Diagnostics, United Kingdom, Revenue ($m) and Market Share (%) by Category, 2010; Table 23: Qiagen N.V., In Vitro Diagnostics, Other Europe, Revenue ($m) and Market Share (%) by Category, 2010; Table 24: Qiagen N.V., In Vitro Diagnostics, Middle East and Africa, Revenue ($m) and Market Share (%) by Category, 2010; Table 25: Qiagen N.V., In Vitro Diagnostics, North America, Revenue ($m) and Market Share (%) by Category, 2010; Table 26: Qiagen N.V., In Vitro Diagnostics, Canada, Revenue ($m) and Market Share (%) by Category, 2010; Table 27: Qiagen N.V., In Vitro Diagnostics, United States, Revenue ($m) and Market Share (%) by Category, 2010; Table 28: Qiagen N.V., In Vitro Diagnostics, South and Central America, Revenue ($m) and Market Share (%) by Category, 2010; Table 29: Qiagen N.V., In Vitro Diagnostics, Brazil, Revenue ($m) and Market Share (%) by Category, 2010; Table 30: Qiagen N.V., In Vitro Diagnostics, Other South and Central America, Revenue ($m) and Market Share (%) by Category, 2010; Table 31: Qiagen N.V., Key Employees; Table 32: Qiagen N.V., Subsidiaries; Table 33: Qiagen N.V., Deals Volume Summary, 2006 to YTD 2011; Table 34: Qiagen N.V., Deals Summary, 2006 to YTD 2011; Table 35: QIAGEN Completes Acquisition Of Molecular Diagnostics Distribution Business; Table 36: QIAGEN Completes Acquisition Of Distribution Business From Diagnostic Technology; Table 37: Orion Genomics Enters Into Licensing Agreement With QIAGEN; Table 38: Mayo Medical Laboratories Enters Into Licensing Agreement With Qiagen; Table 39: Epigenomics Announces Option Licensing Agreement With QIAGEN; Table 40: Epigenomics Enters Into Research Licensing Agreement With QIAGEN; Table 41: Roche Enters Into Licensing Agreement With QIAGEN; Table 42: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University; Table 43: QIAGEN Enters Into An Agreement With Roche And Idaho Technology; Table 44: HandyLab Enters Into An Agreement With Qiagen; Table 45: Corbett Life Science Enters Into Licensing Agreement With Applied Biosystems Group; Table 46: QIAGEN Extends Its Agreement With Epigenomics; Table 47: QIAGEN Enters Into Licensing Agreement With Roche Diagnostics; Table 48: QIAGEN And Ortho-Clinical Diagnostics Enter Into Licensing Agreement; Table 49: QIAGEN Enters Into Co-Development Agreement With Eli Lilly; Table 50: Qiagen Enters Into Co-Development Agreement With Pfizer; Table 51: Olerup Enters Into Co-Marketing Agreement With QIAGEN; Table 52: EyeSense Enters Into An Agreement With QIAGEN; Table 53: QIAGEN Enters Into An Agreement With Abbott; Table 54: QIAGEN Enters Into An Agreement With Genome Diagnostics; Table 55: QIAGEN Enters Into Distribution Agreement With Roche Molecular Systems; Table 56: QIAGEN Enters Into Distribution Agreement With Celera; Table 57: Center for Molecular Medicine Enters Into Research Agreement With QIAGEN; Table 58: QIAGEN Forms Joint Venture With Bio One Capital; Table 59: QIAGEN And Pathway Diagnostics Enter Into Co-Marketing Agreement; Table 60: SEQUENOM Enters Into An Agreement With QIAGEN; Table 61: QIAGEN Enters Into Distribution Agreement With Osmetech Molecular Diagnostics; Table 62: artus Enters Into Distribution Agreement With Corbett Research; Table 63: Veridex Enters Into Co-Marketing Agreement With QIAGEN; Table 64: Biosearch Technologies Enters Into An Agreement With QIAGEN; Table 65: QIAGEN Enters Into Licensing Agreement With BioHelix; Table 66: QIAGEN Completes Private Placement Of Its Common Stock For $640 Million; Table 67: QIAGEN Completes Private Placement Of Notes Due 2026 For $300 Million; Table 68: Qiagen Completes Acquisition Of Cellestis; Table 69: Qiagen To Acquire 61% Stake In IPSOGEN; Table 70: QIAGEN Completes Acquisition Of ESE; Table 71: QIAGEN Completes Acquisition Of SABiosciences; Table 72: QIAGEN Completes Acquisition Of DxS; Table 73: QIAGEN Completes Acquisition Of Explera; Table 74: QIAGEN Acquires Corbett Life Science; Table 75: QIAGEN Acquires Digene; Table 76: QIAGEN Acquires eGene; Table 77: QIAGEN Acquires Genaco Biomedical Products; Table 78: QIAGEN Acquires Shenzhen PG Biotech; Table 79: QIAGEN Acquires Tianwei; Table 80: QIAGEN Acquires QIAGEN Hamburg; Table 81: QIAGEN Acquires Artus; Table 82: USD to Local Currency, Average Exchange Rate, 2010
1.2 List of Figures: Figure 1: In Vitro Diagnostics, Global, Market Share (%), 2010; Figure 2: Qiagen N.V., In Vitro Diagnostics, Global, Market Share (%), 2010; Figure 3: Qiagen N.V., In Vitro Diagnostics, Asia-Pacific, Market Share (%), 2010; Figure 4: Qiagen N.V., In Vitro Diagnostics, Europe, Market Share (%), 2010; Figure 5: Qiagen N.V., In Vitro Diagnostics, North America, Market Share (%), 2010; Figure 6: Qiagen N.V., In Vitro Diagnostics, South and Central America, Market Share (%), 2010; Figure 7: Qiagen N.V., In Vitro Diagnostics, Global, Category Revenue Share (%), 2010; Figure 8: Qiagen N.V., In Vitro Diagnostics, Global, Market Share (%) by Category, 2010; Figure 9: Qiagen N.V., In Vitro Diagnostics, Asia-Pacific, Category Revenue Share (%), 2010; Figure 10: Qiagen N.V., In Vitro Diagnostics, Asia-Pacific, Market Share (%) by Category, 2010; Figure 11: Qiagen N.V., In Vitro Diagnostics, Australia, Category Revenue Share (%), 2010; Figure 12: Qiagen N.V., In Vitro Diagnostics, Australia, Market Share (%) by Category, 2010; Figure 13: Qiagen N.V., In Vitro Diagnostics, China, Category Revenue Share (%), 2010; Figure 14: Qiagen N.V., In Vitro Diagnostics, China, Market Share (%) by Category, 2010; Figure 15: Qiagen N.V., In Vitro Diagnostics, India, Category Revenue Share (%), 2010; Figure 16: Qiagen N.V., In Vitro Diagnostics, India, Market Share (%) by Category, 2010; Figure 17: Qiagen N.V., In Vitro Diagnostics, Japan, Category Revenue Share (%), 2010; Figure 18: Qiagen N.V., In Vitro Diagnostics, Japan, Market Share (%) by Category, 2010; Figure 19: Qiagen N.V., In Vitro Diagnostics, Other Asia-Pacific, Category Revenue Share (%), 2010; Figure 20: Qiagen N.V., In Vitro Diagnostics, Other Asia-Pacific, Market Share (%) by Category, 2010; Figure 21: Qiagen N.V., In Vitro Diagnostics, Europe, Category Revenue Share (%), 2010; Figure 22: Qiagen N.V., In Vitro Diagnostics, Europe, Market Share (%) by Category, 2010; Figure 23: Qiagen N.V., In Vitro Diagnostics, France, Category Revenue Share (%), 2010; Figure 24: Qiagen N.V., In Vitro Diagnostics, France, Market Share (%) by Category, 2010; Figure 25: Qiagen N.V., In Vitro Diagnostics, Germany, Category Revenue Share (%), 2010; Figure 26: Qiagen N.V., In Vitro Diagnostics, Germany, Market Share (%) by Category, 2010; Figure 27: Qiagen N.V., In Vitro Diagnostics, Italy, Category Revenue Share (%), 2010; Figure 28: Qiagen N.V., In Vitro Diagnostics, Italy, Market Share (%) by Category, 2010; Figure 29: Qiagen N.V., In Vitro Diagnostics, Spain, Category Revenue Share (%), 2010; Figure 30: Qiagen N.V., In Vitro Diagnostics, Spain, Market Share (%) by Category, 2010; Figure 31: Qiagen N.V., In Vitro Diagnostics, United Kingdom, Category Revenue Share (%), 2010; Figure 32: Qiagen N.V., In Vitro Diagnostics, United Kingdom, Market Share (%) by Category, 2010; Figure 33: Qiagen N.V., In Vitro Diagnostics, Other Europe, Category Revenue Share (%), 2010; Figure 34: Qiagen N.V., In Vitro Diagnostics, Other Europe, Market Share (%) by Category, 2010; Figure 35: Qiagen N.V., In Vitro Diagnostics, Middle East and Africa, Category Revenue Share (%), 2010; Figure 36: Qiagen N.V., In Vitro Diagnostics, Middle East and Africa, Market Share (%) by Category, 2010; Figure 37: Qiagen N.V., In Vitro Diagnostics, North America, Category Revenue Share (%), 2010; Figure 38: Qiagen N.V., In Vitro Diagnostics, North America, Market Share (%) by Category, 2010; Figure 39: Qiagen N.V., In Vitro Diagnostics, Canada, Category Revenue Share (%), 2010; Figure 40: Qiagen N.V., In Vitro Diagnostics, Canada, Market Share (%) by Category, 2010; Figure 41: Qiagen N.V., In Vitro Diagnostics, United States, Category Revenue Share (%), 2010; Figure 42: Qiagen N.V., In Vitro Diagnostics, United States, Market Share (%) by Category, 2010; Figure 43: Qiagen N.V., In Vitro Diagnostics, South and Central America, Category Revenue Share (%), 2010; Figure 44: Qiagen N.V., In Vitro Diagnostics, South and Central America, Market Share (%) by Category, 2010; Figure 45: Qiagen N.V., In Vitro Diagnostics, Brazil, Category Revenue Share (%), 2010; Figure 46: Qiagen N.V., In Vitro Diagnostics, Brazil, Market Share (%) by Category, 2010; Figure 47: Qiagen N.V., In Vitro Diagnostics, Other South and Central America, Category Revenue Share (%), 2010; Figure 48: Qiagen N.V., In Vitro Diagnostics, Other South and Central America, Market Share (%) by Category, 2010; Figure 49: Qiagen N.V., Deals Volume Summary, 2006 to YTD 2011

Qiagen N.V. Market Share Analysis

Share this report

Other tasks

Research Assistance

Related Markets

Medical Devices Company Reports

Free Alert Me service